The opioid receptor hypothesis A separate line of work proposed that DSIP possesses agonist activity at opiate receptors a hypothesis explicit in the title of the principal human withdrawal paper, which describes DSIP as a neuropeptide with potential agonistic activity on opiate receptors. [13] Supporting animal evidence came from Scherschlichts group, where DSIP at 25.5 mcg/kg IV attenuated naloxone-precipitated withdrawal jumping in morphine-dependent mice
Phase II: Conjugation The liver attaches glutathione, glucuronic acid, sulfate, glycine, taurine, acetyl groups or methyl groups
Chen TS, Richie JP Jr, Lang CA
helps heals tissues, ligaments, bones and muscles
Anthem Blue Cross takes advantage of the additional real estate by going all-in with more graphics, information, and CTA options